Friday, July 10, 2026

pharma · Rheumatoid arthritis · Completely Resected Stage IIB, IIC, and III Melanoma

Celltrion Healthcare Australia

Celltrion Healthcare Australia trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Sydney, AU HQ
9 Employees
TGA registrant Type
Company details
Status
Public
HQ
Sydney, AU
Employees
9
Programs
10
Drugs
44
Patents
0
Intelligence · Clinical Trials

Celltrion Healthcare Australia clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Celltrion Healthcare Australia programs — each row shows trial ID, program name, phase, status, and indication.

Celltrion Healthcare Australia trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Celltrion Healthcare Australia.

  1. CT-P55 3.1 — Phase 3

    Clinical update
  2. CT-P51 3.1 — Phase 3

    Clinical update
  3. CT-P51 1.1 — Phase 1

    Clinical update
  4. CT-P44 3.1 — Phase 3

    Clinical update
  5. CT-P13 3.11 — Phase 3

    Clinical update
  6. CT-L03-301 — Phase 3

    Clinical update
  7. Trastuzumab — Phase 3

    Clinical update
  8. CT-G11 — Phase 1

    Clinical update

Trial registry

10 studies